VistaGen Therapeutics
VTGN
VTGN
85 hedge funds and large institutions have $4.75M invested in VistaGen Therapeutics in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 23 increasing their positions, 25 reducing their positions, and 17 closing their positions.
Holders
85
Holders Change
-7
Holders Change %
-7.61%
% of All Funds
1.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
23
Reduced
25
Closed
17
Calls
$4K
Puts
$2K
Net Calls
+$2K
Net Calls Change
-$401K
Top Buyers
1 |
1
BlackRock
New York
|
$1.26M |
2 |
2
State Street
Boston,
Massachusetts
|
$635K |
3 |
3
Northern Trust
Chicago,
Illinois
|
$180K |
4 |
GWSG
4
GPS Wealth Strategies Group
Centennial,
Colorado
|
$25.3K |
5 |
5
UBS Group
Zurich,
Switzerland
|
$18.3K |